Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

81.8%

-4.7% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

78%

7 of 9 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)